ATE178355T1 - Diagnose der leishmaniose - Google Patents

Diagnose der leishmaniose

Info

Publication number
ATE178355T1
ATE178355T1 AT94907184T AT94907184T ATE178355T1 AT E178355 T1 ATE178355 T1 AT E178355T1 AT 94907184 T AT94907184 T AT 94907184T AT 94907184 T AT94907184 T AT 94907184T AT E178355 T1 ATE178355 T1 AT E178355T1
Authority
AT
Austria
Prior art keywords
leishmania
sample
recombinant
repeat unit
detecting
Prior art date
Application number
AT94907184T
Other languages
English (en)
Inventor
Steven G Reed
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Application granted granted Critical
Publication of ATE178355T1 publication Critical patent/ATE178355T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905Protozoa
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • Y10S530/822Protozoa

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Soft Magnetic Materials (AREA)
  • Power Conversion In General (AREA)
AT94907184T 1993-01-15 1994-01-10 Diagnose der leishmaniose ATE178355T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/006,676 US5411865A (en) 1993-01-15 1993-01-15 Method of detecting anti-leishmania parasite antibodies

Publications (1)

Publication Number Publication Date
ATE178355T1 true ATE178355T1 (de) 1999-04-15

Family

ID=21722052

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94907184T ATE178355T1 (de) 1993-01-15 1994-01-10 Diagnose der leishmaniose

Country Status (8)

Country Link
US (2) US5411865A (de)
EP (1) EP0679259B1 (de)
AT (1) ATE178355T1 (de)
BR (1) BR9405713A (de)
DE (1) DE69417541T2 (de)
ES (1) ES2129630T3 (de)
GR (1) GR3029983T3 (de)
WO (1) WO1994016331A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2705358B1 (fr) * 1993-05-13 1995-08-04 Orstom Procédé de culture in vitro de différents stades de parasites tissulaires, stades parasitaires obtenus et applications biologiques.
US5912166A (en) * 1995-04-21 1999-06-15 Corixa Corporation Compounds and methods for diagnosis of leishmaniasis
US6613337B1 (en) 1997-02-12 2003-09-02 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US5834592A (en) * 1995-09-22 1998-11-10 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis
US6500437B1 (en) 1995-09-22 2002-12-31 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US6365165B1 (en) 1995-09-22 2002-04-02 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis
US6607731B1 (en) 1995-09-22 2003-08-19 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US6638517B2 (en) 1995-09-22 2003-10-28 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US6375955B1 (en) * 1995-09-22 2002-04-23 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US5846748A (en) * 1996-11-15 1998-12-08 The Council Of Scientific & Industrial Research Method for diagnosing visceral leishmaniasis in a patient by identification of a new key marker namely 9-O-acetylated sialoglycoconjugate
US6458359B1 (en) * 1998-12-23 2002-10-01 C.B.F. Leti S.A. Chimeric gene formed by the dna sequences that encode the antigenic determinants of four proteins of l. infantum and protein encoded by said gene, and pharmacuetical composition useful for preventing and/or treating leishmaniosis in animals or humans
US20040241168A1 (en) * 2001-03-16 2004-12-02 O'daly Jose A. Compositions and methods for the treatment and clinical remission of psoriasis
US6673351B1 (en) 2001-03-16 2004-01-06 Astralis, Llc Compositions and methods for the treatment and clinical remission of psoriasis
EP1711520B1 (de) 2003-12-26 2010-02-10 All India Institute of Medical Sciences Polypeptide zur diagnose und therapie von leishmaniasen
US20090028932A1 (en) * 2005-04-15 2009-01-29 Wilson Mary E Vaccine formulations for leishmania
BRPI0710155A2 (pt) * 2006-04-10 2011-08-23 Infectious Disease Res Inst Inc compostos e métodos para diagnóstico e tratamento de leishmaniose
US20090181078A1 (en) * 2006-09-26 2009-07-16 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
PT2486938T (pt) 2006-09-26 2018-06-12 Infectious Disease Res Inst Composição para vacina contendo adjuvante sintético
US20100304461A1 (en) * 2007-06-12 2010-12-02 Brandis John W Portable, Temperature and Chemically Inducible Expression Vector for High Cell Density Expression of Heterologous Genes in Escherichia Coli
WO2009158729A2 (en) * 2008-06-27 2009-12-30 The Infectious Disease Research Institute Inc. Compounds and methods for diagnosis and treatment of chagas disease
EP2291394B1 (de) * 2008-07-03 2017-03-15 Infectious Disease Research Institute Fusionsproteine und ihre verwendung für die diagnose und therapie der leishmaniasis
TWI494125B (zh) * 2009-06-05 2015-08-01 Infectious Disease Res Inst 合成的葡萄吡喃糖基脂質佐劑
BRPI1003744B1 (pt) * 2010-06-08 2021-10-26 Universidade Federal De Ouro Preto E-ntpdases recombinantes, uso na produção de kit de diagnóstico para detecção de anticorpos nas leishmanioses causadas por espécies do gênero leishmania
AU2012243039B2 (en) 2011-04-08 2017-07-13 Immune Design Corp. Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
PL2811981T3 (pl) 2012-02-07 2019-09-30 Infectious Disease Research Institute Ulepszone formulacje adiuwantowe zawierające agonistę TLR4 oraz sposoby ich zastosowania
EA034351B1 (ru) 2012-05-16 2020-01-30 Иммьюн Дизайн Корп. Трехкомпонентная вакцина против впг-2 и способы ее применения
EP2756850A1 (de) * 2013-01-18 2014-07-23 Philipps-Universität Marburg Diagnose einer Leishmania Infektion
ES2728865T3 (es) 2013-03-28 2019-10-29 Infectious Disease Res Inst Vacunas que comprenden polipéptidos de Leishmania para el tratamiento y el diagnóstico de la leishmaniasis
BR112015025709A2 (pt) 2013-04-18 2017-07-18 Immune Design Corp monoterapia com gla para uso em tratamento de câncer
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
PT3089754T (pt) 2013-12-31 2021-07-23 Infectious Disease Res Inst Formulações de vacina de dose única
WO2016055836A1 (pt) * 2014-10-09 2016-04-14 Universidade Federal De Minas Gerais - Ufmg Processo de produção e uso da proteína rk39-kddr e kit para diagnóstico de leishmaniose
AU2017273650B2 (en) 2016-06-01 2022-08-18 Access To Advanced Health Institute Nanoalum particles containing a sizing agent
MX2021014363A (es) 2019-05-25 2022-02-21 Infectious Disease Res Inst Composicion y metodo para secar por pulverizacion una emulsion de vacuna adyuvante.
EP4215916A1 (de) * 2022-01-20 2023-07-26 Philipps-Universität Marburg Test zum nachweis von antikörpern gegen leishmanien

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3581288D1 (de) * 1984-10-01 1991-02-14 Pasteur Institut Antileishmania monoklonale antikoerper, diese antikoerper ausscheidende hybridomas, von diesen antikoerpern erkannte leishmaniaantigene, verfahren zur herstellung und verwendung von diesen monoklonalen antikoerpern und antigenen.
IL82740A0 (en) * 1987-06-01 1987-12-20 Yeda Res & Dev Assay for leishmaniasis
FR2619220B1 (fr) * 1987-08-03 1993-03-26 Pasteur Institut Antigenes specifiques de leishmania et leur procede de preparation, profils antigeniques contenant ces antigenes et leur application au diagnostic des leishmanioses viscerales.
GB8921937D0 (en) * 1989-09-28 1989-11-15 Howard Michael K Diagnostic reagents for leishmaniasis

Also Published As

Publication number Publication date
EP0679259B1 (de) 1999-03-31
DE69417541D1 (de) 1999-05-06
ES2129630T3 (es) 1999-06-16
EP0679259A1 (de) 1995-11-02
GR3029983T3 (en) 1999-07-30
DE69417541T2 (de) 1999-07-15
WO1994016331A1 (en) 1994-07-21
US5411865A (en) 1995-05-02
BR9405713A (pt) 1995-11-28
EP0679259A4 (de) 1997-06-18
US5719263A (en) 1998-02-17

Similar Documents

Publication Publication Date Title
ATE178355T1 (de) Diagnose der leishmaniose
DE60026332D1 (de) Diagnose von einheimischer sprue/zöliakie mit hilfe von gliadinepitopen
ATE69890T1 (de) Nachweis von antigen aktiven aminosaeurensequenzen.
KR850006548A (ko) 프리(pre)-S 유전자 코우드로 된 펩티드 B형 간염 면역원, 왁찐, 진단법 및 합성지질소낭 담체
ATE87655T1 (de) Markierer der t-zelle aktivierung.
BR9500732A (pt) Peptídio imunologicamente ativo,fragmento de DNA isolado,kit de teste e aplicação
PT716697E (pt) Genes e proteinas de leishmania expressos diferencialmente
KR910012244A (ko) 톡소플라스마 곤디 항원, 이의 제조방법 및 이의 용도
Obinata et al. Immunochemical comparison of myosin light chains from chicken fast white, slow red, and cardiac muscle
EP0869177A3 (de) Menschliche Typ-A und Typ-B Blutplättchen abstammenden Wachstumfaktor Rezeptoren
DE3679441D1 (de) Verfahren zur bestimmung von primaeraminen unter verwendung von aromatischen dialdehyden.
EP0293827A3 (de) Probe für Leishmaniosis
ATE143673T1 (de) Testverfahren von glykosylierten proteinen unter verwendung eines antikörpers gerichtet gegen reduzierte glykosylierte n-terminal-aminosäuren
Obinata et al. The subunit structure of myosin from skeletal muscle of the early chick embryo
Michalski et al. Purification and characterisation of a serine-type protease from Eimeria tenella oocysts
NZ233328A (en) Polypeptides produced by hepatocytes infected with p. falciparum; nucleic acid probes
FR2722508B1 (fr) Cassette d'expression d'une proteine p30 de toxoplasma gondii
WO1995021916A3 (en) Pp32: a newly identified cd45-associated protein
DE69011879D1 (de) Immuntestverfahren für zelluläres Eiweiss.
Ichikawa A critical analysis of interface crack models and a quantitative comparison of the classical solution with the modified solution of an interface crack.
PT87001A (pt) Processo para a preparacao de uma vacina contra a disenteria suina e fins analogos
PT95374A (pt) Processo para a preparacao de anticorpos contra sequencias de aminoacidos altamente conservadas de substancias imunogenicas bem como de meios de ensaio imunologico que contenham esses anticorpos
ATE88355T1 (de) Synthetische antigene zur verwendung in der diagnose von malaria, induziert durch plasmodium vivax.
Michalski et al. Molecular characterisation of peanut agglutininbinding glycoproteins from Eimeria tenella
ES2088361B1 (es) Metodo de diagnostico serologico in vitro de la dirofilariosis humana.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties